Samples were obtained as part of a placebo-controlled double-blind study of gene expression profiling of basal cell carcinoma treated topically with Imiquimod, a drug whose activity is mediated through toll-like receptor 7 (TLR-7) signaling [7]. Here, TLR7 is linked to basal cell carcinoma.